Marie Linder

Centre for Pharmacoepidemiology T2, Karolinska Institutet, Sweden

Poster(s):

• (A-033) Utilization of erenumab and other prophylactic migraine treatments: a regulator-mandated population-based cohort study in four Nordic countries (EUPAS36014)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET